Vicasinabin (RG7774) is a potent cannabinoid agonist which is highly selective for the CB2 receptor subtype. It was developed by Roche as a potential agent for the treatment of diabetic retinopathy.
The compounds of every Wikipedia article carrying a Chembox or a Drugbox, refreshed daily, with the values their infoboxes give. The pages need JavaScript; the API does not.